IOB - Delayed Quote EUR
Cellectis S.A. (0WA2.IL)
1.3800
+0.0270
+(2.00%)
At close: 12:00:49 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
22,989
22,989
-24,746
-87,444
-104,562
Investing Cash Flow
-102,808
-102,808
-15,510
-2,761
7,279
Financing Cash Flow
89,113
89,113
82,865
1,145
47,525
End Cash Position
143,251
143,251
136,708
93,216
185,636
Capital Expenditure
-3,843
-3,843
-1,073
-2,441
-18,556
Issuance of Capital Stock
82,822
82,822
67,936
--
44,638
Issuance of Debt
23,201
23,201
29,671
5,750
--
Repayment of Debt
-16,063
-16,063
-16,191
-12,354
-10,641
Repurchase of Capital Stock
-469
--
--
-569
--
Free Cash Flow
19,146
19,146
-25,819
-89,885
-123,118
12/31/2021 - 2/20/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0RV2.IL BioArctic AB (publ)
185.45
0.00%
RGO.SG Regeneron Pharmaceuticals Inc
523.00
+1.04%
VX1.HM Vertex Pharmaceuticals Inc
430.25
-0.21%
VRTX.MX Vertex Pharmaceuticals Incorporated
9,360.00
0.00%
ADCT ADC Therapeutics SA
1.3550
+5.04%
RCUS Arcus Biosciences, Inc.
8.41
+3.64%
ANVS Annovis Bio, Inc.
1.6350
+8.28%